0001209191-19-044613.txt : 20190805 0001209191-19-044613.hdr.sgml : 20190805 20190805170255 ACCESSION NUMBER: 0001209191-19-044613 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190802 FILED AS OF DATE: 20190805 DATE AS OF CHANGE: 20190805 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Witz Pascale CENTRAL INDEX KEY: 0001703723 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35238 FILM NUMBER: 19999436 MAIL ADDRESS: STREET 1: C/O REGULUS THERAPEUTICS INC. STREET 2: 10614 SCIENCE CENTER DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Horizon Therapeutics Public Ltd Co CENTRAL INDEX KEY: 0001492426 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CONNAUGHT HOUSE, 1ST FLOOR STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN STATE: L2 ZIP: 4 BUSINESS PHONE: 011-353-1-772-2100 MAIL ADDRESS: STREET 1: CONNAUGHT HOUSE, 1ST FLOOR STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN STATE: L2 ZIP: 4 FORMER COMPANY: FORMER CONFORMED NAME: Horizon Pharma plc DATE OF NAME CHANGE: 20140919 FORMER COMPANY: FORMER CONFORMED NAME: HORIZON PHARMA, INC. DATE OF NAME CHANGE: 20100520 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-08-02 0 0001492426 Horizon Therapeutics Public Ltd Co HZNP 0001703723 Witz Pascale C/O HORIZON THERAPEUTICS PLC CONNAUGHT HOUSE, 1ST FL, 1 BURLINGTON RD DUBLIN L2 4 IRELAND 1 0 0 0 Ordinary Shares 2019-08-02 4 M 0 8203 A 23499 I By Trust Ordinary Shares 2019-08-02 4 F 0 3220 24.64 D 20279 I By Trust Restricted Stock Units 2019-08-02 4 M 0 8203 0.00 D Ordinary shares 8203 8204 D Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. The shares subject to the restricted stock units vest in three equal annual installments on the anniversary of the grant date (August 2, 2017). /s/ Miles W. McHugh, Attorney-in-Fact 2019-08-05